The Capital Builder The Capital Builder
  • Business
  • Investing
  • Politics
  • Stocks
  • Latests news
Investing

RAD Granted US FDA Fast Track for RAD101 Metastases Imaging

June 11, 2025
Share
Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD Granted US FDA Fast Track for RAD101 Metastases Imaging

Download the PDF here.

This post appeared first on investingnews.com

0
Prev Post

Rapid Increases Land Holding by 26 X

June 11, 2025
Next Post

Hyundai Builds Rare Earths Stockpile to Offset Supply Risks

June 11, 2025

Related Posts

CHARBONE Engages US-Based Investor Relations Firm RBMG

November 1, 2025

CHARBONE Engage la Societe Americaine de Relations aux Investisseurs RBMG

November 1, 2025

LaFleur Minerals Inc.Emerging Among Peers as Attractive, Resilient Investment Play

November 1, 2025

      Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


      By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.


        • About us
        • Contact us
        • Privacy Policy
        • Terms & Conditions

      Copyright © 2025 thecapitalbuilder.com | All Rights Reserved
      • Business
      • Investing
      • Politics
      • Stocks
      • Latests news